LQDA: Liquidia Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,213.69
Enterprise Value ($M) 1,122.47
Book Value ($M) 110.52
Book Value / Share 1.31
Price / Book 10.98
NCAV ($M) 71.84
NCAV / Share 0.85
Price / NCAV 16.89

Profitability (mra)
Return on Invested Capital (ROIC) -0.53
Return on Assets (ROA) -1.01
Return on Equity (ROE) -2.53

Liquidity (mrq)
Quick Ratio 6.33
Current Ratio 6.33

Balance Sheet (mrq) ($M)
Current Assets 214.21
Assets 252.89
Liabilities 142.37
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-12 13G/A Manning Paul B 7.90 5.54
11-08 13G BlackRock, Inc. 5.00 0.00
09-12 13D/A Caligan Partners LP 9.80 16.06
2024-01-16 13G Legend Aggregator, LP 9.50

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 142,666 562,796 25.35
2025-02-03 154,717 988,544 15.65
2025-01-31 161,815 723,256 22.37
2025-01-30 120,486 475,921 25.32

(click for more detail)

Similar Companies
LIXT – Lixte Biotechnology Holdings, Inc. LPCN – Lipocine Inc.
LPTX – Leap Therapeutics, Inc. LSTA – Lisata Therapeutics, Inc.
LTRN – Lantern Pharma Inc.


Financial data and stock pages provided by
Fintel.io